Track topics on Twitter Track topics that are important to you
New End-to-End Platform Integrates Patient Insights, UGC-Style Content and Influencer-Driven Social Media Campaigns
PHILADELPHIA (PRWEB) April 30, 2019
In an effort to close the gap between consumer enthusiasm towards digital health technologies and real-world adoption, WEGO Health announced today the launch of an industry-first service that bundles together consumer insights, consumer-driven content creation, and influencer-driven social media marketing. The announcement coincided with the opening of Digital Health for Pharma, a two-day conference in Philadelphia for senior leaders and innovators in the biopharma industry.
WEGO Health’s new offering is specifically designed to streamline and de-risk the execution of high-impact consumer initiatives by leveraging patient advocates and influencers across the campaign lifecycle. It is intended to work in tandem with pharma teams and their strategic partners to bring to market digital health solutions that can support health and wellness initiatives “beyond the pill.”
“As a company that helps leading pharmaceutical brands collaborate with advocates and influencers to improve the patient experience, we saw a need to create a solution that can substantially increase consumer adoption of digital therapeutics,” said David Goldsmith, WEGO Health’s chief strategy officer. “This is patient-centered innovation by design. It enables pharma teams to execute compelling campaigns that are informed by patient leaders and powered by patient influencers with a proven ability to activate their peers from a place of trust, empathy and credibility.”
WEGO Health’s new offering has three intersecting components, starting with a “Discovery Lab” that translates insights from patient advisory boards and research panels into a digital content and social media strategy designed to activate patients at scale.
The second component is a new virtual “Content Studio,” developed to support the creation of original, patient-driven content such as short-form videos, social posts, interactive Q&A, and blogs. “The Content Studio is where patient insights come to life,” said Goldsmith. “It’s where pharma teams work hand-in-hand with patient advocates who bring authenticity and real-world experience into their messaging and marketing campaigns.”
The final component is an “Activation Engine” that combines proprietary WEGO Health data with social media promotion strategies to activate patients where they are, on leading platforms such as Facebook, Instagram, Twitter and YouTube. The company’s social media campaigns are mass-scale and performance-based to ensure that success is measured by high-value actions tied to awareness and adoption of new therapies and digital health solutions.
About WEGO Health
WEGO Health combines the power of consumer insights and patient-driven content with the science of influencer-driven marketing to deliver unparalleled ROI for the world’s most innovative life sciences companies. Founded in 2007, WEGO Health facilitates collaboration between healthcare companies and a network of more than 100,000 patient advocates, thought leaders and influencers across chronic, complex and rare health conditions. For more information, visit http://www.wegohealth.com.
For the original version on PRWeb visit: https://www.prweb.com/releases/wego_health_activates_patient_influencers_to_help_biopharma_companies_bend_the_digital_health_adoption_curve/prweb16271432.htmNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...